24.05.2022 MEDIQON Group AG  DE0006618309

DGAP-News: MEDIQON Group AG: Annual Report 2021 published – Group growth continued successfully in the 2021 fiscal year


 

DGAP-News: MEDIQON Group AG / Key word(s): Annual Report
MEDIQON Group AG: Annual Report 2021 published – Group growth continued successfully in the 2021 fiscal year

24.05.2022 / 15:56
The issuer is solely responsible for the content of this announcement.


MEDIQON Group AG: Annual Report 2021 published – Group growth continued successfully in the 2021 fiscal year

Today, MEDIQON Group AG published its Annual report 2021. The group’s growth continued successfully in the financial year.

  • In 2021, 10 additional operating companies became part of the group. At the end of the fiscal year, 20 operating companies belonged to the group, two of which were minority holdings in non-public entities.
     
  • The fiscal year 2021, a total of EUR 34.0 MM was invested in the group’s further growth. The total amount invested over the last three years is EUR 67.8 MM, of which EUR 3.1 MM is attributable to the acquisition of minority interests in non-public entities.
     
  • Total group revenue amounts for 2021 amounts to EUR 43.6 MM, thereof EUR 34.4 MM attributable to companies in which the group held a majority stake.
     
  • Adjusted EBITDA of all operating companies belonging to the group in 2021 amounts to EUR 12.8 MM – thereof EUR 11.2 MM attributable to companies in which the group held a majority stake.
     
  • The Base Value amounts to EUR 4.69 per share (previous year EUR 3.46 per share).
     
  • Adjusted Earnings per share amount to EUR 0.38 per share (previous year EUR 0.18 per share).

In addition to the financial statement for MEDIQON Group AG as the parent, the company also published the first-time and voluntarily prepared consolidated accounts which is an important cornerstone present the long-term development of the group more detailed and transparent going forward.

The Annual Report 2021 can be downloaded via the website of the company: Annual and Interim Reports - MEDIQON group AG (mediqon-group.de).



24.05.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MEDIQON Group AG
Herzog-Adolph-Strasse 2
61462 Königstein im Taunus
Germany
Phone: +49 (0) 6174-9687040
Fax: +49 (0) 6174-9687043
E-mail: [email protected]
Internet: www.mediqon-group.de
ISIN: DE0006618309, DE000A254TL0
WKN: 661830, A254TL
Listed: Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart
EQS News ID: 1360355

 
End of News DGAP News Service

1360355  24.05.2022 

fncls.ssp?fn=show_t_gif&application_id=1360355&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 3,21 2,64 0,10 1,08 28,66 42,07 0,00
EBITDA1,2 0,72 8,99 -0,44 -0,61 6,21 10,50 0,00
EBITDA-Marge3 22,43 340,53 -440,00 -56,48 21,67 24,96
EBIT1,4 0,51 8,65 -5,51 -2,56 0,94 2,51 0,00
EBIT-Marge5 15,89 327,65 -5.510,00 -237,04 3,28 5,97 0,00
Jahresüberschuss1 0,54 7,51 -5,01 -2,27 -2,27 -6,60 0,00
Netto-Marge6 16,82 284,47 -5.010,00 -210,19 -7,92 -15,69 0,00
Cashflow1,7 0,75 7,85 -5,00 -1,13 2,87 5,69 0,00
Ergebnis je Aktie8 0,24 3,04 -1,50 -0,18 0,38 0,05 0,23
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Chapters Group
WKN Kurs in € Einschätzung Börsenwert in Mio. €
661830 23,000 Kaufen 379,48
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
46,00 17,40 2,64 73,02
KBV KCV KUV EV/EBITDA
3,89 66,66 9,02 39,56
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 09.07.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
29.09.2023 24.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
15,40% 40,12% 25,68% 61,97%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MEDIQON Group AG  ISIN: DE0006618309 können Sie bei EQS abrufen


Beteiligungen , 661830 , CHG , XETR:CHG